| 1 |
34268965 | Efficacy of transcatheter arterial chemoembolization combined with capecitabine and cetuximab in the treatment of colorectal cancer with liver metastasis. | 2021 May-Jun |
2 |
| 2 |
30315927 | A molecular basis for the synergy between 17‑allylamino‑17‑demethoxy geldanamycin with Capecitabine and Irinotecan in human colorectal cancer cells through VEFG and MMP-9 gene expression. | 2019 Feb 5 |
1 |
| 3 |
29707135 | Capecitabine reverses tumor escape from anti-VEGF through the eliminating CD11bhigh/Gr1high myeloid cells. | 2018 Apr 3 |
1 |
| 4 |
28607065 | Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy. | 2017 Jun 27 |
1 |
| 5 |
26586093 | Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma. | 2016 |
1 |
| 6 |
27057810 | A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer. | 2016 Feb |
1 |
| 7 |
27350037 | Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model. | 2016 Aug |
2 |
| 8 |
26710505 | Drug Induced Lupus Erythematosus Due to Capecitabine and Bevacizumab Treatment Presenting with Prolonged Thrombocytopenia. | 2015 Jul-Sep |
1 |
| 9 |
24374727 | Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. | 2014 Aug 1 |
1 |
| 10 |
24746899 | Anti-angiogenesis participates in antitumor effects of metronomic capecitabine on colon cancer. | 2014 Jul 28 |
2 |
| 11 |
20125120 | The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer. | 2011 Feb |
1 |
| 12 |
17851858 | Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patients. | 2008 |
1 |
| 13 |
16950593 | Metastatic breast cancer: an updating. | 2006 Nov |
2 |